e8vk
 



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report Filed Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report
(Date of earliest event reported): October 20, 2004

Zonagen, Inc.

(Exact name of registrant as specified in its charter)
         
Delaware
(State or other jurisdiction of
incorporation or organization)
  0-21198
(Commission File Number)
  76-0233274
(I.R.S. Employer Identification No.)

2408 Timberloch Place, Suite B-1
The Woodlands, Texas 77380

(Address of principal executive offices and zip code)

(281) 719-3400
(Registrant’s telephone number, including area code)



 


 

Item 7.01 Regulation FD Disclosure

     Zonagen, Inc. (the “Company”) announced in a press release dated October 20, 2004 its financial results for the three months and nine months ended September 30, 2004. A copy of the Company’s press release is attached hereto as Exhibit 99.1. The press release is incorporated by reference herein and the foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.

Item 8.01. Other Information

     The Company announced in a press release on October 20, 2004 that it has filed a registration statement with the Securities and Exchange Commission relating to a proposed underwritten public offering of 4 million shares of its common stock. In addition, Zonagen has granted to the underwriter, Punk, Ziegel & Company, of the public offering an option to purchase up to an additional 600,000 shares to cover over-allotments, if any.

     A copy of the Company’s press release is attached hereto as Exhibit 99.2. The press release is incorporated by reference herein and the foregoing description of the press release is qualified in its entirety by reference to the attached exhibit.

     The information in this report, including each of the Exhibits, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. In addition, the information in this report, including the Exhibit, shall not be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

     c. Exhibits

     
Exhibit    
Number
  Description
99.1
  Press Release dated October 20, 2004 regarding the Company’s financial results.
 
   
99.2
  Press Release dated October 20, 2004 regarding the Company’s registration statement.

 


 

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
  Zonagen, Inc.
 
 
Date: October 22, 2004.  By:   /s/ Joseph S. Podolski   
    Joseph S. Podolski   
    President and Chief Executive Officer   

 


 

         

EXHIBIT INDEX

     
Exhibit    
Number
  Description
99.1
  Press Release dated October 20, 2004 regarding the Company’s financial results.
 
   
99.2
  Press Release dated October 20, 2004 regarding the Company’s registration statement.